Skip to content
HowShorted

bluebird bio, Inc. short interest in 2020

In 2020, bluebird bio, Inc.'s disclosed short interest ran from 15.46% of shares outstanding on 15 Jan 2020 to 10.87% on 31 Dec 2020, a change of -4.59 percentage points. The year's high was 15.46% on 15 Jan 2020 and its low 9.24% on 30 Sep 2020, averaging 12.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.13 days on 14 Feb 2020. Full history: bluebird bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for bluebird bio, Inc. in 2020

2020 in figures

Start of year
15.46% (15 Jan 2020)
End of year
10.87% (31 Dec 2020)
Change
-4.59 pp
High
15.46% (15 Jan 2020)
Low
9.24% (30 Sep 2020)
Average
12.15%
Highest days to cover
14.13 (14 Feb 2020)
SEC filings marked
8

Every report in 2020

bluebird bio, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202015.46%11.04results (8-K)
31 Jan 202015.06%8.29
14 Feb 202014.60%14.13
28 Feb 202014.44%6.7910-K filed, results (8-K)
13 Mar 202013.91%10.09
31 Mar 202013.77%7.27
15 Apr 202013.65%6.53
30 Apr 202013.34%4.51
15 May 202013.79%5.1710-Q filed, results (8-K)
29 May 202013.65%3.71
15 Jun 202013.57%7.33
30 Jun 202013.21%6.49
15 Jul 202012.53%7.47
31 Jul 202010.60%10.87
14 Aug 202010.38%9.9710-Q filed
31 Aug 202010.34%14.02
15 Sep 20209.31%9.92
30 Sep 20209.24%9.54
15 Oct 20209.28%10.11
30 Oct 20209.55%12.41
13 Nov 202010.29%4.0010-Q filed, results (8-K)
30 Nov 202010.31%7.97
15 Dec 202010.48%5.91
31 Dec 202010.87%7.86

See also: bluebird bio, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.